Stanford Health Care Offers New Immunotherapy for Lymphoma
Stanford Health Care Offers New Immunotherapy for Lymphoma
KGOTV-ABC7: Watch Stanford doctors David Miklos, M.D., and Crystal Mackall, M.D., explain this new treatment for blood cancer.
Stanford Health Care is one of 16 sites across the country, and the only one in Northern California to offer this new CAR-T cell therapy for resistant lymphoma, a rare type of blood cancer.
Immunotherapy News from China
- UPDATE 2-U.S. FDA approves Merck immunotherapy/chemo combo …
- …Announces Off-the-Shelf CAR T-cell Cancer Immunotherapy to…
- UPDATE 2-U.S. FDA approves Merck immunotherapy/chemo combo …
- …in Combination With Anti-PD-L1 Cancer Immunotherapy and …
- …Dosed in First-in-Human Clinical Study of Immunotherapy …
- JITC tumor and cancer immunotherapy papers collection
- Welcome to the submission|Journal for ImmunoTherapy of Cancer
- Immunotherapy shows promise for advanced lymphoma: study
- …from the Monotherapy Arm at the Phacilitate Immunotherapy …
- Allergy Immunotherapy Market to exceed US$ 3.33 Bn by 2025 …
Leave a Reply
You must be logged in to post a comment.